NewsRoom Articles - Page 33 of 44

ThursdayOct 13, 2022 10:45 am

Pandemic, Dinosaurs and Raffles: Why Golden Matrix Group Inc. (NASDAQ: GMGI) is a Diamond in the Rough

While a tough economic climate has hurt many businesses in recent years, Golden Matrix has amassed a streak of 16 consecutive profitable quartersThe GMGI portfolio includes over 10,000 games and a turnkey system designed to promote user acquisition, engagement, retention, and monetizationAfter buying 80% of RKings International, GMGI is preparing to expand the business from its roots in the U.K. and Ireland into the Latin American markets The online gambling space is highly competitive, lending to most of the world’s biggest operators burning through tons of cash for marketing in a bid to try and attracts (and keep) customers. That’s…

ThursdayOct 13, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complicationsLexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participantsDominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach $28,797 million by 2026 In the United States, over 121.5 million adults are affected by high blood pressure – with statistics stacked against people of color, those with a family history of high blood pressure,…

TuesdayOct 11, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Offering Solutions to Growing Hypertension Problem Worldwide

Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistantA recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the studyLexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug administration and has been received favorably by the FDA during a pre-Investigational New Drug meeting Hypertension, or high blood pressure, remains one of the world’s most deadly health problems, considered a silent killer because it…

MondayOct 10, 2022 11:15 am

Rosy Outlook for Global Cannabis Market Boosts Hopes for Flora Growth Corp. (NASDAQ: FLGC) as Supply Chain Expands

Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this yearMarket analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billionFlora Growth is levying the potential of recent cooperative agreements to increase the reach of its product distribution pipeline, including new exports to Switzerland, the Czech Republic and the United StatesEurope is predicted to be the fastest-growing region for cannabis sales during the…

FridayOct 07, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertensionA 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten yearsThis decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugsAt the same time, only 24% of adults with hypertension have the condition under control, a statistic attributable to the medications’ troublesome side effectsLexaria’s investigations of its DehydraTECH-CBD have so far presented favorable safety and tolerability data, meaning its drug candidate could offer reprieve to millions looking for antihypertensive drugs…

WednesdayOct 05, 2022 9:45 am

Mullen Automotive Inc. (NASDAQ: MULN) Partners with Global Pioneer in AWG Sector to Develop Water-from-Air EV Solutions

Mullen and Watergen are together developing technology to produce fresh drinking water from the air for in-vehicle consumer and commercial applicationOpportunities for air-to-water vehicle applications are endless, and Mullen is proud to work with Watergen on this game-changing technologyThis innovative tech is envisioned for Mullen’s fleet of EV cargo vans and can be utilized in both commercial and recreational vehicle settings A Car and Driver article points to climbing sales in the U.S. electric vehicle space as one of the signs that the country is accepting EVs (https://ibn.fm/2BclA). This growing acceptance is fueling Mullen Automotive (NASDAQ: MULN) commitment to make EVs…

TuesdayOct 04, 2022 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Expands Global Distribution Network to Three Industry-Leading Countries; Wins Award for Best M&A Deal at the 2022 Benzinga Cannabis Capital Conference

Flora just announced the first successful export of Colombian high-CBD dried cannabis flower to Switzerland and the Czech Republic, as well as CBD isolate to the United StatesLuis Merchan, the company’s CEO, has described this as a “major milestone,” one that further defines the company’s revenue pipelineHe pointed out the increasing demand for Flora’s high-quality, high-margin flower and derivatives from its cultivation operation in Colombia, terming it as a testament to the Flora team’s ability to execute in a very complex global regulatory environmentFlora also earned the Best M&A Deal award at Benzinga’s 2022 Cannabis Capital Conference in Chicago, an…

MondayOct 03, 2022 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focusing on Multiple Mainstream Applications of Its Disruptive Patented DehydraTECH(TM) Technology

Lexaria is the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technologyDehydraTECH is designed to enhance the performance of fat-soluble active pharmaceutical ingredients (“APIs”), molecules, and drugs by increasing their bioavailabilityThrough animal and human studies, Lexaria has shown that DehydraTECH increases the bioavailability of antiviral drugs, CBD, oral nicotine and moreThe company is focusing on multiple mainstream applications of its technology that rerrcould address serious unmet patient needsLexaria is currently keen on developing a potential treatment for hypertension Last summer, drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) announced a review of its successful 2021 antiviral drug program. The…

MondayOct 03, 2022 9:20 am

Business Booming for Golden Matrix Group Inc. (NASDAQ: GMGI) as Online Gambling Continues Growth in Popularity

Data Bridge Market Research forecasts a 13.7% CAGR for the casino online gambling market to reach $144.74 billion in 2028Golden Matrix Group is demonstrating growth in both its B2B and B2C businesses, as it prepares to enter the Mexican marketsGMGI revenue for the first nine months of fiscal 2022 was $26.46 million, up 237% from a year earlier, while the company notched its 16th consecutive profitable quarter For decades, there was little substantial innovation in the gambling industry and then along came the miracle of the internet and changed everything with the emergence on online gaming. Still, most traditional casino…

FridaySep 30, 2022 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strategic Acquisitions, Expanding Cannabis Exports Give Significant Boost to Company’s Revenue Streams

Flora Growth is a global cannabis cultivator, product builder, and supplier, experiencing continued growth thanks to strategic acquisitions and an expanding supply chain for marketing its brands in various countriesFlora announced its most recent acquisition in September — a deal to acquire the assets of the No Cap Hemp Co. brand in exchange for payment of 10 percent of the No Cap brand revenues up to a maximum of $2 million The deal grants Flora an immediate revenue stream free of closing cost considerationsFlora has seen revenues skyrocket over the past year, with a 604 percent YOY increase in the H1…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000